Navigation Links
Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
Date:4/2/2008

l partner on clinical development and funding are pending.

The program for measles and RSV will be tested up to and through clinical Phase I, where it is expected that proof of concept will be obtained.

As for HIV multiantigen, Phase I/II clinical studies will be completed, and partnering negotiations will be initiated as and when the project progresses.

Building market demand for IMVAMUNE(R)

As part of the process of taking the Bavarian Nordic organization to new and professional levels, a new commercial organization was established in 2007 in order to strengthen the Company's commercial activities and build market demand for IMVAMUNE(R) and future vaccines, including HIV and cancer vaccines.

Changes in management

During the past year the Executive Management of Bavarian Nordic has been strengthened with new CEO and an Executive Vice President Commercial Affairs. To implement the new strategic initiatives, the Executive Management will be further strengthened with two new people and the appointment of a new member.

Rene Djurup, Executive Vice President Technical Operations, has decided to resign from his position as of 31 May 2008 in order to dedicate himself to private business activities. The build-up of the Company's production facility - the world's first MVA production plant, was a fantastic achievement headed by Rene, and the Company wishes to thank him for his great effort and contribution to the industrial development of Bavarian Nordic.

Anders Gram (48) has been appointed as new Executive Vice President Technical Operations. Anders holds an M.Sc. degree in chemical engineering and a Ph.D. in industrial biochemistry. He currently holds the position as Managing Director and Vice President, Biopharma Operations in Novozymes. Previously he worked in various management positions within product supply in the enzyme business area at Novo Nordisk. He will take up position on 1 June 2008 at the latest.


'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
2. Vista Partners Updates Coverage; Maintains $3.20 Target Price
3. ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
4. NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update
5. SGX Pharmaceuticals Provides Update on SGX523 Clinical Trials
6. ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
7. ImaRx to Report Corporate Updates and 4Q07 Financial Results
8. LUMEDX Updates Real-Time Patient and Resource Scheduler for Healthcare Systems
9. InfuSystem Holdings Provides Business Update and Comments on Fourth Quarter 2007 Financial Results
10. Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008
11. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... -- According to a new market report ... Asia to Witness Highest Growth by ... culture market was valued at US$ 586.1 Mn in 2014 ... 29.1% to account for US$ 2,717.6 Mn by 2020. ... 3D cell culture refers to a process ...
(Date:7/31/2015)... ... July 31, 2015 , ... Global Resorcinol ... premium industry insights on the global resorcinol industry. The report highlights the various ... vivid market scenarios and analysis of primary and secondary inputs from the existing ...
(Date:7/30/2015)... , July 30, 2015 AACC ... to the 2015 AACC Annual Meeting & Clinical ... from July 26–30. The meeting showcased revolutionary advancements ... the ability of healthcare providers to diagnose patients ... effective medical treatment. As of ...
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
Breaking Biology Technology:Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4
... Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), a leading ... from the oral hearing on 6 December 2011 at the European ... 1 536 827 " Further use of protein kinase N beta ... PKN3, protein kinase N beta, targeted by Silence,s lead program Atu027, ...
... 2011 Medicare carrier Palmetto GBA is proposing new processes ... molecular diagnostic tests (MDT) and laboratory-developed tests (LDT) in the ... marks the first known effort by a payer to address ... genetic tests and molecular diagnostics assays. These important ...
... 2011 Monsanto , a major biotech ... has been given the  Worst Company of 2011 ... environment. The award was given by  natural health ... Monsanto the worst company of 2011. ...
Cached Biology Technology:Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office 2Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office 3Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office 4Why Medicare Carrier Proposes Major Changes in the Handling of Code Stacked Molecular Test Claims is Topic of December 20 Audio Conference 2Monsanto Declared Worst Company of 2011 by NaturalSociety 2
(Date:7/9/2015)... Calif. , July 9, 2015  Unchained ... today announcing its acquisition of Avid Nano. Avid ... light scattering (DLS) systems.    Also ... smallest, fastest and easiest to use protein sizing ... that measures a protein,s hydrodynamic size, size distribution, ...
(Date:7/8/2015)... July 8, 2015 The consumer products ... summer,s must have products such as wearables, smart wallets & ... for biometrics based devices continues to rapidly grow.  Biometrics & ... NXTD ), Google Inc. (NASDAQ: GOOG ), Apple ... ), GoPro, Inc. (NASDAQ: GPRO ) and Baidu Inc. ...
(Date:7/2/2015)... 25, 2015 Research and ... "Next Generation Biometrics Market by Application, Technology, Function ... to their offering. The next generation biometrics ... at a CAGR of 17.9% between 2015 and 2020 ... for the market. Safran SA ( ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
... through the 133 page record of the 2006-2007 activities of ... youll see why they recently took home the nations most ... fundraiser. Youll find the detailed lesson plans that honor ... 75 fifth grades at Spreckels elementary school last year. Youll ...
... scientists including researchers at Cold Spring Harbor Laboratory (CSHL) ... neural stem and progenitor cells (NPCs) to be tracked, ... important advance could lead to significantly better diagnosis and ... neurological and psychiatric disorders. The biomarker is a ...
... major role in an international scientific team that has ... related fruit fly species. As well has having implications ... immune systems -- the analysis paves the way for ... results of the research, the Cornell scientists coordinated one ...
Cached Biology News:UC-San Diego Engineering Honor Society wins most outstanding chapter award 2Team of scientists develops non-invasive method to track nerve-cell development in live human brain 2International team compares 12 fruit fly genomes 2International team compares 12 fruit fly genomes 3
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Phospho-SEK1/MKK4 (Thr261) Antibody...
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
BACE (CT) rabbit polyclonal antibody...
Biology Products: